Skip to main content
Full access
Communications and Updates
Published Online: 1 September 2014

Response to Mattes

To the Editor: The report of highly significant differences between persons with schizophrenia and comparison subjects in the right hippocampus should not be misinterpreted to suggest that effects are strongly lateralized. Total hippocampal intrinsic resting activity was reanalyzed by averaging activity across both the left and right hippocampi. Schizophrenia patients showed greater response than control subjects (t=2.6, p=0.013), indicating that total intrinsic hippocampal activity is indeed elevated in patients.
In our previous work, the most significant group differences have been reported in either the left or right hemisphere but were often present bilaterally at more liberal statistical thresholds. For example, in our 2012 study of the effects of distracting noise on hippocampal response and attention networks (1), we reported higher left hippocampal activity in patients in response to distracting noise at a significance threshold of p<0.01, but greater activity also was observed in the right hippocampus at a threshold of p<0.02 (t=2.5). Similarly, in our 2011 study to determine whether the alpha 7-nicotinic partial agonist 3-(2,4-dimethoxybenzylidene)-anabaseine (DMXB-A) can lower hippocampal hyperactivity in schizophrenia patients (2), the threshold for the primary result, reduction of right hippocampal activity, was reported at p<0.01. However, at a threshold of p<0.04 (t=2.0), the drug also was associated with reduced activity of the left hippocampus. These observations are consistent with the larger imaging literature, which suggests that both structural and functional hippocampal differences in schizophrenia are consistently observed in both the right and left structures (3).

References

1.
Tregellas JR, Smucny J, Eichman L, Rojas DC: The effect of distracting noise on the neuronal mechanisms of attention in schizophrenia. Schizophr Res 2012; 142:230–236
2.
Tregellas JR, Olincy A, Johnson L, Tanabe J, Shatti S, Martin LF, Singel D, Du YP, Soti F, Kem WR, Freedman R: Functional magnetic resonance imaging of effects of a nicotinic agonist in schizophrenia. Neuropsychopharmacology 2010; 35:938–942
3.
Preston AR, Shohamy D, Tamminga CA, Wagner AD: Hippocampal function, declarative memory, and schizophrenia: anatomic and functional neuroimaging considerations. Curr Neurol Neurosci Rep 2005; 5:249–256

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 1001
PubMed: 25178756

History

Accepted: June 2014
Published online: 1 September 2014
Published in print: September 2014

Authors

Affiliations

Jason R. Tregellas, Ph.D.
From the Research Service, Denver VA Medical Center, and Department of Psychiatry, University of Colorado School of Medicine, Aurora, Colo.

Competing Interests

The author’s disclosures accompany the original article.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share